(Q37710866)

22 August 2017

ROR2 is a novel prognostic biomarker and a potential therapeutic target in leiomyosarcoma and gastrointestinal stromal tumour (English)

1 reference

22 August 2017

0 references

0 references

1 reference

Thomas Mühlenberg

3

0 references

Matt van de Rijn

15

object named as

Matt van de Rijn

1 reference

22 August 2017

7

Shirley Zhu

1 reference

22 August 2017

0 references

Badreddin Edris

1

1 reference

22 August 2017

Iñigo Espinosa

2

1 reference

22 August 2017

Amanda Mikels

4

1 reference

22 August 2017

Cheng-Han Lee

5

1 reference

22 August 2017

Sonja E Steigen

6

1 reference

22 August 2017

Kelli D Montgomery

8

1 reference

22 August 2017

Alexander J F Lazar

9

1 reference

22 August 2017

Dina Lev

10

1 reference

22 August 2017

Jonathan A Fletcher

11

1 reference

22 August 2017

Andrew H Beck

12

1 reference

22 August 2017

Robert B West

13

1 reference

22 August 2017

Roel Nusse

14

1 reference

22 August 2017

17 February 2012

1 reference

22 August 2017

1 reference

22 August 2017

227

1 reference

22 August 2017

2

1 reference

22 August 2017

223-233

1 reference

describes a project that uses

22 August 2017

0 references

0 references

0 references

The orphan tyrosine kinase receptor, ROR2, mediates Wnt5A signaling in metastatic melanoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3992120

Ror2 receptor requires tyrosine kinase activity to mediate Wnt5A signaling

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3992120

Autonomous regulation of osteosarcoma cell invasiveness by Wnt5a/Ror2 signaling

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3992120

Ror2, a developmentally regulated kinase, promotes tumor growth potential in renal cell carcinoma

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3992120

Gene expression profiling for the investigation of soft tissue sarcoma pathogenesis and the identification of diagnostic, prognostic, and predictive biomarkers

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3992120

Specific mutations in the beta-catenin gene (CTNNB1) correlate with local recurrence in sporadic desmoid tumors.

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3992120

The receptor tyrosine kinase Ror2 is involved in non-canonical Wnt5a/JNK signalling pathway

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3992120

Molecular portraits of human breast tumours

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3992120

Ror2, encoding a receptor-like tyrosine kinase, is required for cartilage and growth plate development

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3992120

Distinctive gene expression patterns in human mammary epithelial cells and breast cancers

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3992120

ETV1 is a lineage survival factor that cooperates with KIT in gastrointestinal stromal tumours

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3992120

Expression of insulin-like growth factor 2 in mesenchymal neoplasms

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3992120

Receptor tyrosine kinase Ror2 mediates Wnt5a-induced polarized cell migration by activating c-Jun N-terminal kinase via actin-binding protein filamin A.

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3992120

Prognostic significance of macrophage infiltration in leiomyosarcomas.

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3992120

Diagnostic and prognostic markers for gastrointestinal stromal tumors in Norway

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3992120

Initial and late resistance to imatinib in advanced gastrointestinal stromal tumors are predicted by different prognostic factors: a European Organisation for Research and Treatment of Cancer-Italian Sarcoma Group-Australasian Gastrointestinal Trial

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3992120

Acquired resistance to imatinib in gastrointestinal stromal tumor occurs through secondary gene mutation

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3992120

The discovery of receptor tyrosine kinases: targets for cancer therapy

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3992120

Heat shock protein 90 inhibition in imatinib-resistant gastrointestinal stromal tumor.

1 September 2018

1 reference

Crossref

https://api.crossref.org/works/10.1002%2FPATH.3986

The role of KIT in the management of patients with gastrointestinal stromal tumors

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1002%2FPATH.3986

21 January 2018

Identifiers

DOI

10.1002/PATH.3986

1 reference

22 August 2017

1 reference

22 August 2017

PubMed publication ID

22294416

1 reference